异基因移植后单药达沙替尼治疗伴……的B细胞急性淋巴细胞白血病的反应 - Suppr

Response to single agent dasatinib post allogeneic transplant in B-cell acute lymphoblastic leukemia with .

作者信息

Aldoss Ibrahim, Pullarkat Vinod

机构信息

Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, CA, USA.

出版信息

Leuk Lymphoma. 2019 Nov;60(11):2832-2834. doi: 10.1080/10428194.2019.1605510. Epub 2019 Apr 24.

DOI:10.1080/10428194.2019.1605510

PMID:31014138

Abstract

摘要

相似文献

Response to single agent dasatinib post allogeneic transplant in B-cell acute lymphoblastic leukemia with .异基因移植后单药达沙替尼治疗伴……的B细胞急性淋巴细胞白血病的反应

Leuk Lymphoma. 2019 Nov;60(11):2832-2834. doi: 10.1080/10428194.2019.1605510. Epub 2019 Apr 24.

ETV6-ABL1 fusion combined with monosomy 7 in childhood B-precursor acute lymphoblastic leukemia.儿童B前体急性淋巴细胞白血病中ETV6-ABL1融合基因与7号染色体单体联合存在的情况

Int J Hematol. 2018 May;107(5):604-609. doi: 10.1007/s12185-017-2371-5. Epub 2017 Nov 24.

Successful treatment of the first adult case of ZMIZ1::ABL1-positive B cell lymphoblastic leukemia with dasatinib, chimeric antigen receptor T-cell therapy, and allogeneic hematopoietic stem cell transplantation.达沙替尼、嵌合抗原受体T细胞疗法和异基因造血干细胞移植成功治疗首例成人ZMIZ1::ABL1阳性B细胞淋巴细胞白血病病例

Cancer Genet. 2024 Jun;284-285:16-19. doi: 10.1016/j.cancergen.2024.03.005. Epub 2024 Mar 8.

NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors.NUP214-ABL1融合基因定义了一种罕见的B细胞前体急性淋巴细胞白血病亚型，该亚型可能从酪氨酸激酶抑制剂中获益。

Haematologica. 2016 Apr;101(4):e133-4. doi: 10.3324/haematol.2015.136499. Epub 2015 Dec 17.

B-Cell Precursor-Acute Lymphoblastic Leukemia With EBF1-PDGFRB Fusion Treated With Hematopoietic Stem Cell Transplantation and Imatinib: A Case Report and Literature Review.采用造血干细胞移植和伊马替尼治疗的伴有EBF1-PDGFRB融合基因的B细胞前体急性淋巴细胞白血病：病例报告及文献复习

J Pediatr Hematol Oncol. 2021 Jan;43(1):e105-e108. doi: 10.1097/MPH.0000000000001743.

Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia.B细胞急性淋巴细胞白血病中NUP214-ABL1融合基因的附加体扩增

Blood. 2012 Nov 22;120(22):4441-3. doi: 10.1182/blood-2012-09-456517.

Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with -positive acute lymphoblastic leukemia.达沙替尼和异基因干细胞移植使一名老年B细胞阳性急性淋巴细胞白血病患者获得持续缓解。

Haematologica. 2017 Apr;102(4):e160-e162. doi: 10.3324/haematol.2016.160531. Epub 2017 Jan 5.

Larotrectinib in TRK fusion-positive pediatric B-cell acute lymphoblastic leukemia.拉罗替尼治疗 TRK 融合阳性小儿 B 细胞急性淋巴细胞白血病。

Blood Adv. 2019 Nov 26;3(22):3499-3502. doi: 10.1182/bloodadvances.2019000700.

Durable remissions in positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation.使用博纳吐单抗和干细胞移植治疗阳性急性淋巴细胞白血病的持久缓解。

Haematologica. 2019 Jun;104(6):e244-e247. doi: 10.3324/haematol.2018.210104. Epub 2019 Feb 14.

Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with SNX2-ABL1 chimeric transcript.一名患有伴有SNX2-ABL1嵌合转录本的前体B细胞急性淋巴细胞白血病儿童对酪氨酸激酶抑制剂反应不佳。

Eur J Haematol. 2014 Mar;92(3):263-7. doi: 10.1111/ejh.12234. Epub 2013 Nov 28.

引用本文的文献

Clinical, Phenotypic and Molecular Characterization of Fusion Positive Myeloid Malignancies.融合阳性髓系恶性肿瘤的临床、表型及分子特征

J Med Cases. 2024 Sep;15(9):250-255. doi: 10.14740/jmc4286. Epub 2024 Aug 22.

Detection of Hybrid Fusion Transcripts, Aberrant Transcript Expression, and Specific Single Nucleotide Variants in Acute Leukemia and Myeloid Disorders with Recurrent Gene Rearrangements.检测急性白血病和伴有复发性基因重排的髓系疾病中的混合融合转录本、异常转录本表达和特定单核苷酸变异。

Pathobiology. 2024;91(1):76-88. doi: 10.1159/000532085. Epub 2023 Jul 25.

Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.Ph 样急性淋巴细胞白血病伴 ABL1 重排患者对达沙替尼的快速分子反应：病例系列和文献复习。

Ann Hematol. 2023 Sep;102(9):2397-2402. doi: 10.1007/s00277-023-05236-z. Epub 2023 Apr 27.

Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic :: Gene Fusion.病例报告：特定的 ABL 抑制剂伊马替尼是治疗伴有隐匿性::基因融合的 B 细胞急性淋巴细胞白血病的一线有效靶向药物。

Pathol Oncol Res. 2022 Sep 12;28:1610570. doi: 10.3389/pore.2022.1610570. eCollection 2022.

Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL.Ph 样急性淋巴细胞白血病相关融合基因的成人异基因造血细胞移植的结局。

Blood Adv. 2022 Sep 13;6(17):4936-4948. doi: 10.1182/bloodadvances.2022007597.

Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy.隐匿性 NUP214-ABL1 导致的 B-ALL 对化疗耐药，可通过激酶抑制和免疫治疗克服。

Oncologist. 2022 Mar 4;27(2):82-86. doi: 10.1093/oncolo/oyab052.

Case Report: The First Report of Fusion Gene in Acute Myeloid Leukemia Patient Detected by Next-Generation Sequencing.病例报告：通过下一代测序检测到的急性髓系白血病患者融合基因的首例报告。

Front Oncol. 2021 Jul 8;11:706798. doi: 10.3389/fonc.2021.706798. eCollection 2021.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to single agent dasatinib post allogeneic transplant in B-cell acute lymphoblastic leukemia with .

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献